• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素信号抑制肿瘤相关组织嗜酸性粒细胞浸润,促进乳腺癌生长。

Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth.

机构信息

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Sci Adv. 2024 Sep 27;10(39):eadp2442. doi: 10.1126/sciadv.adp2442.

DOI:10.1126/sciadv.adp2442
PMID:39331714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11430468/
Abstract

Estrogens regulate eosinophilia in asthma and other inflammatory diseases. Further, peripheral eosinophilia and tumor-associated tissue eosinophilia (TATE) predicts a better response to immune checkpoint blockade (ICB) in breast cancer. However, how and if estrogens affect eosinophil biology in tumors and how this influences ICB efficacy has not been determined. Here, we report that estrogens decrease the number of peripheral eosinophils and TATE, and this contributes to increased tumor growth in validated murine models of breast cancer and melanoma. Moreover, estrogen signaling in healthy female mice also suppressed peripheral eosinophil prevalence by decreasing the proliferation and survival of maturing eosinophils. Inhibiting estrogen receptor (ER) signaling decreased tumor growth in an eosinophil-dependent manner. Further, the efficacy of ICBs was increased when administered in combination with anti-estrogens. These findings highlight the importance of ER signaling as a regulator of eosinophil biology and TATE and highlight the potential near-term clinical application of ER modulators to increase ICB efficacy in multiple tumor types.

摘要

雌激素调节哮喘和其他炎症性疾病中的嗜酸性粒细胞增多症。此外,外周血嗜酸性粒细胞增多和肿瘤相关组织嗜酸性粒细胞增多(TATE)预测乳腺癌对免疫检查点阻断(ICB)的反应更好。然而,雌激素如何以及是否影响肿瘤中的嗜酸性粒细胞生物学,以及这如何影响 ICB 的疗效尚未确定。在这里,我们报告雌激素减少外周血嗜酸性粒细胞和 TATE 的数量,这导致乳腺癌和黑色素瘤的已验证小鼠模型中的肿瘤生长增加。此外,健康雌性小鼠中的雌激素信号通过减少成熟嗜酸性粒细胞的增殖和存活来抑制外周血嗜酸性粒细胞的流行。抑制雌激素受体(ER)信号以嗜酸性粒细胞依赖性方式降低肿瘤生长。此外,当与抗雌激素联合使用时,ICB 的疗效增加。这些发现强调了 ER 信号作为调节嗜酸性粒细胞生物学和 TATE 的重要性,并强调了 ER 调节剂的潜在近期临床应用,以增加多种肿瘤类型的 ICB 疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/f779d79734b2/sciadv.adp2442-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/3a1640b08883/sciadv.adp2442-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/587b9ebde234/sciadv.adp2442-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/936ebeba3b66/sciadv.adp2442-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/1af4332a81e2/sciadv.adp2442-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/8147c763bda3/sciadv.adp2442-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/b8f946e3efb6/sciadv.adp2442-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/1046eab4227a/sciadv.adp2442-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/f779d79734b2/sciadv.adp2442-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/3a1640b08883/sciadv.adp2442-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/587b9ebde234/sciadv.adp2442-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/936ebeba3b66/sciadv.adp2442-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/1af4332a81e2/sciadv.adp2442-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/8147c763bda3/sciadv.adp2442-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/b8f946e3efb6/sciadv.adp2442-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/1046eab4227a/sciadv.adp2442-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefa/11430468/f779d79734b2/sciadv.adp2442-f8.jpg

相似文献

1
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth.雌激素信号抑制肿瘤相关组织嗜酸性粒细胞浸润,促进乳腺癌生长。
Sci Adv. 2024 Sep 27;10(39):eadp2442. doi: 10.1126/sciadv.adp2442.
2
Eosinophilia in cancer and its regulation by sex hormones.癌症中的嗜酸性粒细胞增多及其与性激素的调节
Trends Endocrinol Metab. 2023 Jan;34(1):5-20. doi: 10.1016/j.tem.2022.11.002. Epub 2022 Nov 26.
3
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.抑制髓系细胞中的雌激素信号转导可增强黑色素瘤的肿瘤免疫。
J Clin Invest. 2021 Dec 1;131(23). doi: 10.1172/JCI151347.
4
Estradiol administration controls eosinophilia through estrogen receptor-alpha activation during acute peritoneal inflammation.雌二醇通过急性腹膜炎症期间的雌激素受体-α激活来控制嗜酸性粒细胞增多症。
J Leukoc Biol. 2011 Jul;90(1):145-54. doi: 10.1189/jlb.0210073. Epub 2011 Apr 15.
5
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.叉头框转录因子FOXO3a抑制雌激素依赖性乳腺癌细胞的增殖和肿瘤发生。
Breast Cancer Res. 2008;10(1):R21. doi: 10.1186/bcr1872. Epub 2008 Feb 29.
6
Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.胰岛素样生长因子 1 受体在雌激素受体信号通路中的代偿作用及其成为激素治疗抵抗性乳腺癌的可能治疗靶点。
Breast Cancer. 2019 May;26(3):272-281. doi: 10.1007/s12282-018-0922-0. Epub 2018 Oct 16.
7
EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.EPRS是雌激素受体阳性(ER+)乳腺癌中细胞增殖和雌激素信号传导的关键调节因子。
Oncotarget. 2016 Oct 25;7(43):69592-69605. doi: 10.18632/oncotarget.11870.
8
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.患者来源的管腔乳腺癌异种移植保留了激素受体异质性,并有助于确定独特的雌激素依赖性基因特征。
Breast Cancer Res Treat. 2012 Sep;135(2):415-32. doi: 10.1007/s10549-012-2164-8. Epub 2012 Jul 24.
9
CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.CHRNA5属于在乳腺癌中具有预后意义的次级雌激素信号网络。
Cell Oncol (Dordr). 2021 Apr;44(2):453-472. doi: 10.1007/s13402-020-00581-x. Epub 2021 Jan 19.
10
Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.雌激素和抗雌激素通过 GPER1-PRKACA-CMA 通路稳定 MORC2,促进乳腺癌细胞的增殖和内分泌耐药。
Autophagy. 2020 Jun;16(6):1061-1076. doi: 10.1080/15548627.2019.1659609. Epub 2019 Sep 6.

引用本文的文献

1
Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19.嗜酸性粒细胞减少预示着感染新冠病毒奥密克戎变异株的肺癌患者预后不良。
Front Med (Lausanne). 2025 Jul 9;12:1583843. doi: 10.3389/fmed.2025.1583843. eCollection 2025.
2
Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanoma.转移性葡萄膜黑色素瘤中伊匹单抗和纳武单抗的真实毒性及预后的回顾性多中心分析
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf173.
3
Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms.

本文引用的文献

1
Comprehensive reference intervals for white blood cell counts during pregnancy.妊娠期白细胞计数的综合参考区间。
BMC Pregnancy Childbirth. 2024 Jan 5;24(1):35. doi: 10.1186/s12884-023-06227-8.
2
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2.一项关于拉索昔芬联合阿贝西利治疗既往治疗后疾病进展的伴有ESR1突变的转移性ER+/HER2-乳腺癌女性患者的开放标签、II期、多中心研究:ELAINE 2。
Ann Oncol. 2023 Dec;34(12):1131-1140. doi: 10.1016/j.annonc.2023.09.3103.
3
Blocking of oestrogen signals improves anti-tumour effect regardless of oestrogen receptor alpha expression in cancer cells.
慢性阻塞性肺疾病加重期(ECOPD)表型的特征:与住院结局及免疫炎症机制的关联
Int J Chron Obstruct Pulmon Dis. 2025 May 22;20:1613-1624. doi: 10.2147/COPD.S505016. eCollection 2025.
4
Global, regional, and national burden of premenopausal and postmenopausal malignant melanoma from 1990 to 2021: a comprehensive cross-sectional analysis.1990年至2021年全球、区域和国家绝经前和绝经后恶性黑色素瘤负担:一项全面的横断面分析
Am J Cancer Res. 2025 Mar 15;15(3):1002-1019. doi: 10.62347/QBVC1497. eCollection 2025.
5
Harnessing myeloid cells in cancer.利用癌症中的髓样细胞。
Mol Cancer. 2025 Mar 6;24(1):69. doi: 10.1186/s12943-025-02249-2.
6
Interaction between Estrogen Receptors and p53: A Broader Role for Tamoxifen?雌激素受体与p53之间的相互作用:他莫昔芬的作用更广泛?
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf020.
7
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies.PD-1/PD-L1 免疫检查点阻断在乳腺癌中的研究进展与增敏策略。
Mol Cancer. 2024 Nov 29;23(1):266. doi: 10.1186/s12943-024-02176-8.
阻断雌激素信号可改善抗肿瘤效果,而与癌细胞中雌激素受体 α 的表达无关。
Br J Cancer. 2023 Oct;129(6):935-946. doi: 10.1038/s41416-023-02381-0. Epub 2023 Aug 3.
4
Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer.聚焦 NK 细胞和 ADCC:HER2 阳性乳腺癌靶向治疗中一种有前景的免疫治疗方法。
Front Immunol. 2022 Dec 19;13:1083462. doi: 10.3389/fimmu.2022.1083462. eCollection 2022.
5
IL-5-producing CD4 T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.产生 IL-5 的 CD4 T 细胞和嗜酸性粒细胞共同作用,增强乳腺癌对免疫检查点阻断的反应。
Cancer Cell. 2023 Jan 9;41(1):106-123.e10. doi: 10.1016/j.ccell.2022.11.014. Epub 2022 Dec 15.
6
Eosinophilia in cancer and its regulation by sex hormones.癌症中的嗜酸性粒细胞增多及其与性激素的调节
Trends Endocrinol Metab. 2023 Jan;34(1):5-20. doi: 10.1016/j.tem.2022.11.002. Epub 2022 Nov 26.
7
Breast Cancer Statistics, 2022.2022 年乳腺癌统计数据。
CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3.
8
Human differentiated eosinophils release IL-13 in response to IL-33 stimulation.人源分化的嗜酸性粒细胞在受到 IL-33 刺激时会释放 IL-13。
Front Immunol. 2022 Sep 13;13:946643. doi: 10.3389/fimmu.2022.946643. eCollection 2022.
9
Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy.肿瘤微环境中的嗜酸性粒细胞与淋巴细胞相互作用及癌症免疫治疗。
Nat Immunol. 2022 Sep;23(9):1309-1316. doi: 10.1038/s41590-022-01291-2. Epub 2022 Aug 24.
10
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.帕博利珠单抗联合化疗治疗晚期三阴性乳腺癌。
N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809.